-
1
-
-
84892805731
-
Cancer statistics
-
Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics. CA Cancer J Clin 2014, 2014(64):9-29.
-
(2014)
CA Cancer J Clin
, vol.2014
, Issue.64
, pp. 9-29
-
-
Siegel, R.1
Ma, J.2
Zou, Z.3
Jemal, A.4
-
2
-
-
84862013453
-
Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
-
Tenbaum S.P., Ordonez-Moran P., Puig I., Chicote I., Arques O., Landolfi S., et al. beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med 2012, 18:892-901.
-
(2012)
Nat Med
, vol.18
, pp. 892-901
-
-
Tenbaum, S.P.1
Ordonez-Moran, P.2
Puig, I.3
Chicote, I.4
Arques, O.5
Landolfi, S.6
-
3
-
-
84870666240
-
Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles
-
Shen J., Sun H., Xu P., Yin Q., Zhang Z., Wang S., et al. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles. Biomaterials 2013, 34:1581-1590.
-
(2013)
Biomaterials
, vol.34
, pp. 1581-1590
-
-
Shen, J.1
Sun, H.2
Xu, P.3
Yin, Q.4
Zhang, Z.5
Wang, S.6
-
4
-
-
84862880702
-
Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer
-
Choi K.Y., Jeon E.J., Yoon H.Y., Lee B.S., Na J.H., Min K.H., et al. Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer. Biomaterials 2012, 33:6186-6193.
-
(2012)
Biomaterials
, vol.33
, pp. 6186-6193
-
-
Choi, K.Y.1
Jeon, E.J.2
Yoon, H.Y.3
Lee, B.S.4
Na, J.H.5
Min, K.H.6
-
5
-
-
33846100356
-
Ahuman colon cancer cell capable of initiating tumour growth in immunodeficient mice
-
O'Brien C.A., Pollett A., Gallinger S., Dick J.E. Ahuman colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
-
(2007)
Nature
, vol.445
, pp. 106-110
-
-
O'Brien, C.A.1
Pollett, A.2
Gallinger, S.3
Dick, J.E.4
-
6
-
-
84866175348
-
Doxorubicin-loaded silk films: drug-silk interactions and invivo performance in human orthotopic breast cancer
-
Seib F.P., Kaplan D.L. Doxorubicin-loaded silk films: drug-silk interactions and invivo performance in human orthotopic breast cancer. Biomaterials 2012, 33:8442-8450.
-
(2012)
Biomaterials
, vol.33
, pp. 8442-8450
-
-
Seib, F.P.1
Kaplan, D.L.2
-
7
-
-
84892533825
-
MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition
-
He Q., Shi J. MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition. Adv Mater 2014, 26:391-411.
-
(2014)
Adv Mater
, vol.26
, pp. 391-411
-
-
He, Q.1
Shi, J.2
-
8
-
-
79953147370
-
Aperspective on cancer cell metastasis
-
Chaffer C.L., Weinberg R.A. Aperspective on cancer cell metastasis. Science 2011, 331:1559-1564.
-
(2011)
Science
, vol.331
, pp. 1559-1564
-
-
Chaffer, C.L.1
Weinberg, R.A.2
-
9
-
-
36849067019
-
Nanocarriers as an emerging platform for cancer therapy
-
Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
-
(2007)
Nat Nanotechnol
, vol.2
, pp. 751-760
-
-
Peer, D.1
Karp, J.M.2
Hong, S.3
Farokhzad, O.C.4
Margalit, R.5
Langer, R.6
-
10
-
-
83555166219
-
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
-
Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011, 6:815-823.
-
(2011)
Nat Nanotechnol
, vol.6
, pp. 815-823
-
-
Cabral, H.1
Matsumoto, Y.2
Mizuno, K.3
Chen, Q.4
Murakami, M.5
Kimura, M.6
-
11
-
-
84870236985
-
Anticancer nanomedicine and tumor vascular permeability; where is the missing link?
-
Taurin S., Nehoff H., Greish K. Anticancer nanomedicine and tumor vascular permeability; where is the missing link?. JControl Release 2012, 164:265-275.
-
(2012)
JControl Release
, vol.164
, pp. 265-275
-
-
Taurin, S.1
Nehoff, H.2
Greish, K.3
-
12
-
-
84886751441
-
Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
-
Sun T.M., Wang Y.C., Wang F., Du J.Z., Mao C.Q., Sun C.Y., et al. Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds. Biomaterials 2014, 35:836-845.
-
(2014)
Biomaterials
, vol.35
, pp. 836-845
-
-
Sun, T.M.1
Wang, Y.C.2
Wang, F.3
Du, J.Z.4
Mao, C.Q.5
Sun, C.Y.6
-
13
-
-
34548392267
-
FDA drug approval summary: pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)
-
Dinndorf P.A., Gootenberg J., Cohen M.H., Keegan P., Pazdur R. FDA drug approval summary: pegaspargase (Oncaspar (R)) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist 2007, 12:991-998.
-
(2007)
Oncologist
, vol.12
, pp. 991-998
-
-
Dinndorf, P.A.1
Gootenberg, J.2
Cohen, M.H.3
Keegan, P.4
Pazdur, R.5
-
14
-
-
84867689207
-
Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects
-
Deng C., Jiang Y., Cheng R., Meng F., Zhong Z. Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: promises, progress and prospects. Nano Today 2012, 7:467-480.
-
(2012)
Nano Today
, vol.7
, pp. 467-480
-
-
Deng, C.1
Jiang, Y.2
Cheng, R.3
Meng, F.4
Zhong, Z.5
-
15
-
-
34347254640
-
Establishment of human tumor xenografts in immunodeficient mice
-
Morton C.L., Houghton P.J. Establishment of human tumor xenografts in immunodeficient mice. Nat Protoc 2007, 2:247-250.
-
(2007)
Nat Protoc
, vol.2
, pp. 247-250
-
-
Morton, C.L.1
Houghton, P.J.2
-
16
-
-
0346250110
-
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis
-
Jenkins D.E., Oei Y., Hornig Y.S., Yu S.F., Dusich J., Purchio T., et al. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin Exp 2003, 20:733-744.
-
(2003)
Clin Exp
, vol.20
, pp. 733-744
-
-
Jenkins, D.E.1
Oei, Y.2
Hornig, Y.S.3
Yu, S.F.4
Dusich, J.5
Purchio, T.6
-
17
-
-
84892370492
-
Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery
-
Ruggeri B.A., Camp F., Miknyoczki S. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery. Biochem Pharmacol 2014, 87:150-161.
-
(2014)
Biochem Pharmacol
, vol.87
, pp. 150-161
-
-
Ruggeri, B.A.1
Camp, F.2
Miknyoczki, S.3
-
18
-
-
33845206491
-
Practices and pitfalls of mouse cancer models in drug discovery
-
Kung A.L. Practices and pitfalls of mouse cancer models in drug discovery. Adv Cancer Res 2007, 96:191-212.
-
(2007)
Adv Cancer Res
, vol.96
, pp. 191-212
-
-
Kung, A.L.1
-
19
-
-
33645736793
-
Genetically engineered models have advantages over xenografts for preclinical studies
-
Becher O.J., Holland E.C. Genetically engineered models have advantages over xenografts for preclinical studies. Cancer Res 2006, 66:3355-3358.
-
(2006)
Cancer Res
, vol.66
, pp. 3355-3358
-
-
Becher, O.J.1
Holland, E.C.2
-
20
-
-
79953719071
-
Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease
-
Takahashi M., Hori M., Mutoh M., Wakabayashi K., Nakagama H. Experimental animal models of pancreatic carcinogenesis for prevention studies and their relevance to human disease. Cancers 2011, 3:582-602.
-
(2011)
Cancers
, vol.3
, pp. 582-602
-
-
Takahashi, M.1
Hori, M.2
Mutoh, M.3
Wakabayashi, K.4
Nakagama, H.5
-
21
-
-
70249123827
-
Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications
-
Abel E.L., Angel J.M., Kiguchi K., DiGiovanni J. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 2009, 4:1350-1362.
-
(2009)
Nat Protoc
, vol.4
, pp. 1350-1362
-
-
Abel, E.L.1
Angel, J.M.2
Kiguchi, K.3
DiGiovanni, J.4
-
22
-
-
84868649424
-
An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis
-
Smith P.A., Merritt D., Barr L., Thorley-Lawson D.A. An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis. Genes Cancer 2011, 2:1023-1033.
-
(2011)
Genes Cancer
, vol.2
, pp. 1023-1033
-
-
Smith, P.A.1
Merritt, D.2
Barr, L.3
Thorley-Lawson, D.A.4
-
23
-
-
84893732819
-
Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin
-
Li M., Tang Z., Lv S., Song W., Hong H., Jing X., et al. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin. Biomaterials 2014, 35:3851-3864.
-
(2014)
Biomaterials
, vol.35
, pp. 3851-3864
-
-
Li, M.1
Tang, Z.2
Lv, S.3
Song, W.4
Hong, H.5
Jing, X.6
-
24
-
-
70349482671
-
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
-
Teesalu T., Sugahara K.N., Kotamraju V.R., Ruoslahti E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A 2009, 106:16157-16162.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 16157-16162
-
-
Teesalu, T.1
Sugahara, K.N.2
Kotamraju, V.R.3
Ruoslahti, E.4
-
25
-
-
77952901022
-
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
-
Sugahara K.N., Teesalu T., Karmali P.P., Kotamraju V.R., Agemy L., Greenwald D.R., et al. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs. Science 2010, 328:1031-1035.
-
(2010)
Science
, vol.328
, pp. 1031-1035
-
-
Sugahara, K.N.1
Teesalu, T.2
Karmali, P.P.3
Kotamraju, V.R.4
Agemy, L.5
Greenwald, D.R.6
-
26
-
-
84868316414
-
Methoxypoly(ethylene glycol)-block-Poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers
-
Song W., Li M., Tang Z., Li Q., Yang Y., Liu H., et al. Methoxypoly(ethylene glycol)-block-Poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers. Macromol Biosci 2012, 12:1514-1523.
-
(2012)
Macromol Biosci
, vol.12
, pp. 1514-1523
-
-
Song, W.1
Li, M.2
Tang, Z.3
Li, Q.4
Yang, Y.5
Liu, H.6
-
27
-
-
84877037947
-
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells
-
Gu G., Gao X., Hu Q., Kang T., Liu Z., Jiang M., et al. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells. Biomaterials 2013, 34:5138-5148.
-
(2013)
Biomaterials
, vol.34
, pp. 5138-5148
-
-
Gu, G.1
Gao, X.2
Hu, Q.3
Kang, T.4
Liu, Z.5
Jiang, M.6
-
28
-
-
84892650579
-
Cancer nanomedicine: from drug delivery to imaging
-
216rv4
-
Chow E.K., Ho D. Cancer nanomedicine: from drug delivery to imaging. Sci Transl Med 2013, 5:216rv4.
-
(2013)
Sci Transl Med
, vol.5
-
-
Chow, E.K.1
Ho, D.2
-
29
-
-
84875258437
-
The anti-tumor efficiency of poly(L-glutamic acid) dendrimers with polyhedral oligomeric silsesquioxane cores
-
Pu Y.J., Chang S., Yuan H., Wang G., He B., Gu Z.W. The anti-tumor efficiency of poly(L-glutamic acid) dendrimers with polyhedral oligomeric silsesquioxane cores. Biomaterials 2013, 34:3658-3666.
-
(2013)
Biomaterials
, vol.34
, pp. 3658-3666
-
-
Pu, Y.J.1
Chang, S.2
Yuan, H.3
Wang, G.4
He, B.5
Gu, Z.W.6
-
30
-
-
84887626984
-
Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells
-
Ke X.Y., Lin Ng V.W., Gao S.J., Tong Y.W., Hedrick J.L., Yang Y.Y. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells. Biomaterials 2014, 35:1096-1108.
-
(2014)
Biomaterials
, vol.35
, pp. 1096-1108
-
-
Ke, X.Y.1
Lin Ng, V.W.2
Gao, S.J.3
Tong, Y.W.4
Hedrick, J.L.5
Yang, Y.Y.6
-
31
-
-
33646179475
-
Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis
-
Sengottuvelan M., Viswanathan P., Nalini N. Chemopreventive effect of trans-resveratrol-a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis. Carcinogenesis 2006, 27:1038-1046.
-
(2006)
Carcinogenesis
, vol.27
, pp. 1038-1046
-
-
Sengottuvelan, M.1
Viswanathan, P.2
Nalini, N.3
-
32
-
-
84880139404
-
Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy
-
Wang J., Sun X., Mao W., Sun W., Tang J., Sui M., et al. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. Adv Mater 2013, 25:3670-3676.
-
(2013)
Adv Mater
, vol.25
, pp. 3670-3676
-
-
Wang, J.1
Sun, X.2
Mao, W.3
Sun, W.4
Tang, J.5
Sui, M.6
-
33
-
-
84862803234
-
Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy
-
Fu C., Lin L., Shi H., Zheng D., Wang W., Gao S., et al. Hydrophobic poly (amino acid) modified PEI mediated delivery of rev-casp-3 for cancer therapy. Biomaterials 2012, 33:4589-4596.
-
(2012)
Biomaterials
, vol.33
, pp. 4589-4596
-
-
Fu, C.1
Lin, L.2
Shi, H.3
Zheng, D.4
Wang, W.5
Gao, S.6
-
34
-
-
72449122860
-
Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells
-
Li Y.L., Zhu L., Liu Z., Cheng R., Meng F., Cui J.H., et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed 2009, 48:9914-9918.
-
(2009)
Angew Chem Int Ed
, vol.48
, pp. 9914-9918
-
-
Li, Y.L.1
Zhu, L.2
Liu, Z.3
Cheng, R.4
Meng, F.5
Cui, J.H.6
-
35
-
-
39649120532
-
Areview of stimuli-responsive nanocarriers for drug and gene delivery
-
Ganta S., Devalapally H., Shahiwala A., Amiji M. Areview of stimuli-responsive nanocarriers for drug and gene delivery. JControl Release 2008, 126:187-204.
-
(2008)
JControl Release
, vol.126
, pp. 187-204
-
-
Ganta, S.1
Devalapally, H.2
Shahiwala, A.3
Amiji, M.4
-
36
-
-
84893454622
-
Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy
-
Sun C.Y., Dou S., Du J.Z., Yang X.Z., Li Y.P., Wang J. Doxorubicin conjugate of poly(ethylene glycol)-block-polyphosphoester for cancer therapy. Adv Healthc Mater 2014, 3:261-272.
-
(2014)
Adv Healthc Mater
, vol.3
, pp. 261-272
-
-
Sun, C.Y.1
Dou, S.2
Du, J.Z.3
Yang, X.Z.4
Li, Y.P.5
Wang, J.6
-
37
-
-
84886752329
-
The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors
-
Wang J., Wu W., Zhang Y., Wang X., Qian H., Liu B., et al. The combined effects of size and surface chemistry on the accumulation of boronic acid-rich protein nanoparticles in tumors. Biomaterials 2014, 35:866-878.
-
(2014)
Biomaterials
, vol.35
, pp. 866-878
-
-
Wang, J.1
Wu, W.2
Zhang, Y.3
Wang, X.4
Qian, H.5
Liu, B.6
-
38
-
-
79952008706
-
The effect of surface charge on invivo biodistribution of PEG-oligocholic acid based micellar nanoparticles
-
Xiao K., Li Y., Luo J., Lee J.S., Xiao W., Gonik A.M., et al. The effect of surface charge on invivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011, 32:3435-3446.
-
(2011)
Biomaterials
, vol.32
, pp. 3435-3446
-
-
Xiao, K.1
Li, Y.2
Luo, J.3
Lee, J.S.4
Xiao, W.5
Gonik, A.M.6
-
39
-
-
84890255976
-
Doxorubicin-loaded boron-rich polymer nanoparticles for orthotopically implanted liver tumor treatment
-
Zhang L.Z., Zhang Y.J., Wu W., Jiang X.Q. Doxorubicin-loaded boron-rich polymer nanoparticles for orthotopically implanted liver tumor treatment. Chin J Polym Sci 2013, 31:778-786.
-
(2013)
Chin J Polym Sci
, vol.31
, pp. 778-786
-
-
Zhang, L.Z.1
Zhang, Y.J.2
Wu, W.3
Jiang, X.Q.4
-
40
-
-
84887041117
-
Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery
-
Ding J., Xu W., Zhang Y., Sun D., Xiao C., Liu D., et al. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery. JControl Release 2013, 172:444-455.
-
(2013)
JControl Release
, vol.172
, pp. 444-455
-
-
Ding, J.1
Xu, W.2
Zhang, Y.3
Sun, D.4
Xiao, C.5
Liu, D.6
-
41
-
-
84899995755
-
Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer
-
Lv S., Tang Z., Li M., Lin J., Song W., Liu H., et al. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer. Biomaterials 2014, 35:6118-6129.
-
(2014)
Biomaterials
, vol.35
, pp. 6118-6129
-
-
Lv, S.1
Tang, Z.2
Li, M.3
Lin, J.4
Song, W.5
Liu, H.6
-
42
-
-
84900854455
-
Cancer-targeted monodisperse mesoporous silica nanoparticles as carrier of ruthenium polypyridyl complexes to enhance theranostic effects
-
He L.Z., Huang Y.Y., Zhu H.L., Pang G.H., Zheng W.J., Wong Y.S., et al. Cancer-targeted monodisperse mesoporous silica nanoparticles as carrier of ruthenium polypyridyl complexes to enhance theranostic effects. Adv Funct Mater 2014, 24:2754-2763.
-
(2014)
Adv Funct Mater
, vol.24
, pp. 2754-2763
-
-
He, L.Z.1
Huang, Y.Y.2
Zhu, H.L.3
Pang, G.H.4
Zheng, W.J.5
Wong, Y.S.6
-
43
-
-
84906076240
-
Peptide dendrimer-doxorubicin conjugate-based nanoparticle as an enzyme-responsive drug delivery system for cancer therapy
-
Zhang C., Pan D., Luo K., She W., Guo C., Yang Y., et al. Peptide dendrimer-doxorubicin conjugate-based nanoparticle as an enzyme-responsive drug delivery system for cancer therapy. Adv Healthc Mater 2014, 3:1299-1308.
-
(2014)
Adv Healthc Mater
, vol.3
, pp. 1299-1308
-
-
Zhang, C.1
Pan, D.2
Luo, K.3
She, W.4
Guo, C.5
Yang, Y.6
-
44
-
-
84885478909
-
Gamma aminobutyric acid B and 5-hydroxy tryptamine 2A receptors functional regulation during enhanced liver cell proliferation by GABA and 5-HT chitosan nanoparticles treatment
-
Shilpa J., Pretty M.A., Anitha M., Paulose C.S. Gamma aminobutyric acid B and 5-hydroxy tryptamine 2A receptors functional regulation during enhanced liver cell proliferation by GABA and 5-HT chitosan nanoparticles treatment. Eur J Pharmacol 2013, 715:154-163.
-
(2013)
Eur J Pharmacol
, vol.715
, pp. 154-163
-
-
Shilpa, J.1
Pretty, M.A.2
Anitha, M.3
Paulose, C.S.4
-
45
-
-
33748331308
-
The mighty mouse: genetically engineered mouse models in cancer drug development
-
Sharpless N.E., Depinho R.A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006, 5:741-754.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 741-754
-
-
Sharpless, N.E.1
Depinho, R.A.2
-
46
-
-
84877718308
-
Carnitines slow down tumor development of colon cancer in the DMH-chemical carcinogenesis mouse model
-
Roscilli G., Marra E., Mori F., Di Napoli A., Mancini R., Serlupi-Crescenzi O., et al. Carnitines slow down tumor development of colon cancer in the DMH-chemical carcinogenesis mouse model. JCell Biochem 2013, 114:1665-1673.
-
(2013)
JCell Biochem
, vol.114
, pp. 1665-1673
-
-
Roscilli, G.1
Marra, E.2
Mori, F.3
Di Napoli, A.4
Mancini, R.5
Serlupi-Crescenzi, O.6
-
47
-
-
0022620203
-
Different autochthonous models of colorectal cancer in the rat
-
Amberger H. Different autochthonous models of colorectal cancer in the rat. JCancer Res Clin Oncol 1986, 111:157-159.
-
(1986)
JCancer Res Clin Oncol
, vol.111
, pp. 157-159
-
-
Amberger, H.1
-
48
-
-
84875840252
-
Adrug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release
-
You J.O., Guo P., Auguste D.T. Adrug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. Angew Chem Int Ed 2013, 52:4141-4146.
-
(2013)
Angew Chem Int Ed
, vol.52
, pp. 4141-4146
-
-
You, J.O.1
Guo, P.2
Auguste, D.T.3
-
49
-
-
84867824357
-
Imaging metastasis using an integrin-targeting chain-shaped nanoparticle
-
Peiris P.M., Toy R., Doolittle E., Pansky J., Abramowski A., Tam M., et al. Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS Nano 2012, 6:8783-8795.
-
(2012)
ACS Nano
, vol.6
, pp. 8783-8795
-
-
Peiris, P.M.1
Toy, R.2
Doolittle, E.3
Pansky, J.4
Abramowski, A.5
Tam, M.6
-
50
-
-
84875618078
-
Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes
-
Ma X., Zhou J., Zhang C.X., Li X.Y., Li N., Ju R.J., et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials 2013, 34:4452-4465.
-
(2013)
Biomaterials
, vol.34
, pp. 4452-4465
-
-
Ma, X.1
Zhou, J.2
Zhang, C.X.3
Li, X.Y.4
Li, N.5
Ju, R.J.6
-
51
-
-
84855802810
-
Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy
-
Zhang F., Braun G.B., Pallaoro A., Zhang Y., Shi Y., Cui D., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
-
(2012)
Nano Lett
, vol.12
, pp. 61-67
-
-
Zhang, F.1
Braun, G.B.2
Pallaoro, A.3
Zhang, Y.4
Shi, Y.5
Cui, D.6
-
52
-
-
77950227877
-
Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging
-
El-Boubbou K., Zhu D.C., Vasileiou C., Borhan B., Prosperi D., Li W., et al. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. JAm Chem Soc 2010, 132:4490-4499.
-
(2010)
JAm Chem Soc
, vol.132
, pp. 4490-4499
-
-
El-Boubbou, K.1
Zhu, D.C.2
Vasileiou, C.3
Borhan, B.4
Prosperi, D.5
Li, W.6
-
53
-
-
84906784257
-
Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes
-
Liang C., Diao S., Wang C., Gong H., Liu T., Hong G., et al. Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes. Adv Mater 2014, 26:5646-5652.
-
(2014)
Adv Mater
, vol.26
, pp. 5646-5652
-
-
Liang, C.1
Diao, S.2
Wang, C.3
Gong, H.4
Liu, T.5
Hong, G.6
|